Nawaloka Hospitals PLC (COSE:NHL.N0000)
Sri Lanka · Delayed Price · Currency is LKR 0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Nawaloka Hospitals Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 14,133 | 13,243 | 11,013 | 10,379 | 9,305 | 15,302 | |
Revenue Growth | 20.00% | 20.25% | 6.10% | 11.54% | -39.19% | 29.38% |
Cost of Revenue | 6,162 | 5,911 | 5,321 | 4,763 | 4,670 | 7,461 |
Gross Profit | 7,971 | 7,332 | 5,692 | 5,617 | 4,635 | 7,841 |
Selling, General & Admin | 6,155 | 5,625 | 4,723 | 4,618 | 3,860 | 4,856 |
Other Operating Expenses | -166.8 | -127.48 | -143.9 | -37.47 | 258.91 | 232.59 |
Operating Expenses | 6,106 | 5,615 | 4,579 | 4,592 | 4,709 | 5,927 |
Operating Income | 1,865 | 1,717 | 1,113 | 1,025 | -73.46 | 1,914 |
Interest Expense | -951.94 | -1,000 | -927.89 | -1,491 | -1,951 | -1,035 |
Interest & Investment Income | 16.17 | 23.98 | 28.95 | 37.56 | 58.58 | 53.46 |
Earnings From Equity Investments | 155.09 | 155.09 | 223.04 | 148.53 | 159.89 | - |
Currency Exchange Gain (Loss) | -3.41 | -3.41 | 4.3 | 33.73 | -102.56 | -215 |
Other Non Operating Income (Expenses) | 0 | -0 | 0 | - | -2.08 | -7.64 |
EBT Excluding Unusual Items | 1,081 | 891.97 | 441.1 | -247.01 | -1,911 | 709.67 |
Gain (Loss) on Sale of Investments | 2.1 | 2.1 | 0.41 | - | - | - |
Gain (Loss) on Sale of Assets | 14.81 | 14.81 | 0.82 | - | - | -253.66 |
Asset Writedown | 0.63 | 0.63 | -105.68 | - | - | - |
Other Unusual Items | -0 | 660.76 | - | - | - | - |
Pretax Income | 1,099 | 1,570 | 336.64 | -247.01 | -1,911 | 456.02 |
Income Tax Expense | 732.15 | 515.84 | 280.26 | 57.74 | 527.67 | 552.61 |
Net Income | 366.74 | 1,054 | 56.38 | -304.75 | -2,438 | -96.59 |
Net Income to Common | 366.74 | 1,054 | 56.38 | -304.75 | -2,438 | -96.59 |
Net Income Growth | -50.32% | 1770.19% | - | - | - | - |
Shares Outstanding (Basic) | 1,416 | 1,410 | 1,410 | 1,410 | 1,410 | 1,410 |
Shares Outstanding (Diluted) | 1,416 | 1,410 | 1,410 | 1,410 | 1,410 | 1,410 |
Shares Change | -0.29% | - | - | - | - | - |
EPS (Basic) | 0.26 | 0.75 | 0.04 | -0.22 | -1.73 | -0.07 |
EPS (Diluted) | 0.26 | 0.75 | 0.04 | -0.22 | -1.73 | -0.07 |
EPS Growth | -50.17% | 1770.21% | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 274.87 | -1,430 | 792.79 | 2,047 | 2,752 | 1,259 |
Free Cash Flow Per Share | 0.19 | -1.01 | 0.56 | 1.45 | 1.95 | 0.89 |
Gross Margin | 56.40% | 55.36% | 51.69% | 54.12% | 49.81% | 51.24% |
Operating Margin | 13.20% | 12.96% | 10.10% | 9.87% | -0.79% | 12.51% |
Profit Margin | 2.60% | 7.96% | 0.51% | -2.94% | -26.21% | -0.63% |
Free Cash Flow Margin | 1.94% | -10.80% | 7.20% | 19.73% | 29.58% | 8.23% |
EBITDA | 2,809 | 2,611 | 1,915 | 1,851 | 754.97 | 2,744 |
EBITDA Margin | 19.88% | 19.72% | 17.39% | 17.83% | 8.11% | 17.93% |
D&A For EBITDA | 943.98 | 894.28 | 802.41 | 825.97 | 828.43 | 830.28 |
EBIT | 1,865 | 1,717 | 1,113 | 1,025 | -73.46 | 1,914 |
EBIT Margin | 13.20% | 12.96% | 10.10% | 9.87% | -0.79% | 12.51% |
Effective Tax Rate | 66.63% | 32.85% | 83.25% | - | - | 121.18% |